Final Approval For RX Cetirizine Hydrochloride Syrup ANDA
Abbreviated New Drug Application (ANDA) for prescription Cetirizine Hydrochloride Syrup (cetirizine syrup) is produced by a multinational, science-based pharmaceutical company, called Taro Pharmaceutical Industries Ltd. This company had received experimental approval for this ANDA in October 2007 and today it has received final approval from the U.S. Food and Drug Administration (FDA).
Generic Cetirizine syrup is a prescription allergy medication effective for symptoms of perennial allergic rhinitis in children of 6 to 23 months, and for chronic urticaria (hives) in children of 6 months to 5 years. As many specialists suggest, Taro’s Cetirizine allergy syrup is bioequivalent to McNeil Consumer Healthcare’s Zyrtec Syrup.
According to the data, Taro’s Cetirizine hydrochloride syrup is widely used because annual U.S. sales of this kind of allergy relief products were nearly $150 million.
Taro Pharmaceuticals is aimed to meet needs of its customers, manufacturing is always developing. Taro expects more physician, pharmacist or patient acceptance of Cetirizine drug syrup and other products. Besides, the Company plans to market the highest quality healthcare products in the U.S.A. and other countries.
You can buy Cetirizine in our online canadian pharmacy.
